Identification of Restriction-Modification Systems of Bifidobacterium animalis subsp. lactis CNCM I-2494 by SMRT Sequencing and Associated Methylome Analysis

Bifidobacterium animalis subsp. lactis CNCM I-2494 is a component of a commercialized fermented dairy product for which beneficial effects on health has been studied by clinical and preclinical trials. To date little is known about the molecular mechanisms that could explain the beneficial effects that bifidobacteria impart to the host. Restriction-modification (R-M) systems have been identified as key obstacles in the genetic accessibility of bifidobacteria, and circumventing these is a prerequisite to attaining a fundamental understanding of bifidobacterial attributes, including the genes that are responsible for health-promoting properties of this clinically and industrially important group of bacteria. The complete genome sequence of B. animalis subsp. lactis CNCM I-2494 is predicted to harbour the genetic determinants for two type II R-M systems, designated BanLI and BanLII. In order to investigate the functionality and specificity of these two putative R-M systems in B. animalis subsp. lactis CNCM I-2494, we employed PacBio SMRT sequencing with associated methylome analysis. In addition, the contribution of the identified R-M systems to the genetic accessibility of this strain was assessed.

[1]  Richard J. Roberts,et al.  REBASE—a database for DNA restriction and modification: enzymes, genes and genomes , 2009, Nucleic Acids Res..

[2]  F. Turroni,et al.  Bifidobacteria and humans: our special friends, from ecological to genomics perspectives. , 2014, Journal of the science of food and agriculture.

[3]  Aldert L. Zomer,et al.  Comparative genomics of the Bifidobacterium breve taxon , 2014, BMC Genomics.

[4]  Tyson A. Clark,et al.  Global methylation state at base-pair resolution of the Caulobacter genome throughout the cell cycle , 2013, Proceedings of the National Academy of Sciences.

[5]  I. Feussner,et al.  Identification and characterization of an oleate hydratase-encoding gene from Bifidobacterium breve , 2013, Bioengineered.

[6]  R. P. Ross,et al.  Metabolism of Four α-Glycosidic Linkage-Containing Oligosaccharides by Bifidobacterium breve UCC2003 , 2013, Applied and Environmental Microbiology.

[7]  B. Mayo,et al.  Mobilome and genetic modification of bifidobacteria. , 2013, Beneficial microbes.

[8]  B. Naliboff,et al.  Consumption of fermented milk product with probiotic modulates brain activity. , 2013, Gastroenterology.

[9]  D. van Sinderen,et al.  Transposon Mutagenesis in Bifidobacterium breve: Construction and Characterization of a Tn5 Transposon Mutant Library for Bifidobacterium breve UCC2003 , 2013, PloS one.

[10]  D. Sinderen,et al.  Molecular dialogue between the human gut microbiota and the host: a Lactobacillus and Bifidobacterium perspective , 2013, Cellular and Molecular Life Sciences.

[11]  C. Riedel,et al.  Tough nuts to crack , 2013, Bioengineered.

[12]  D. Sinderen,et al.  Transcriptional and functional characterization of genetic elements involved in galacto-oligosaccharide utilization by Bifidobacterium breve UCC2003 , 2012, Microbial biotechnology.

[13]  Tyson A. Clark,et al.  Enhanced 5-methylcytosine detection in single-molecule, real-time sequencing via Tet1 oxidation , 2013, BMC Biology.

[14]  Tyson A. Clark,et al.  Genome-wide mapping of methylated adenine residues in pathogenic Escherichia coli using single-molecule real-time sequencing , 2012, Nature Biotechnology.

[15]  Richard J. Roberts,et al.  The methylomes of six bacteria , 2012, Nucleic acids research.

[16]  F. Turroni,et al.  Host-microbe interactions that facilitate gut colonization by commensal bifidobacteria. , 2012, Trends in microbiology.

[17]  Á. Gil,et al.  Probiotic Mechanisms of Action , 2012, Annals of Nutrition and Metabolism.

[18]  P. Álvarez-Martín,et al.  A Two-Component Regulatory System Controls Autoregulated Serpin Expression in Bifidobacterium breve UCC2003 , 2012, Applied and Environmental Microbiology.

[19]  D. van Sinderen,et al.  A bile‐inducible membrane protein mediates bifidobacterial bile resistance , 2012, Microbial biotechnology.

[20]  Tohru Suzuki,et al.  A targeted gene knockout method using a newly constructed temperature-sensitive plasmid mediated homologous recombination in Bifidobacterium longum , 2012, Applied Microbiology and Biotechnology.

[21]  Aldert L. Zomer,et al.  A Conserved Two-Component Signal Transduction System Controls the Response to Phosphate Starvation in Bifidobacterium breve UCC2003 , 2012, Applied and Environmental Microbiology.

[22]  Jing Yuan,et al.  Accessing the Inaccessible: Molecular Tools for Bifidobacteria , 2012, Applied and Environmental Microbiology.

[23]  S. Fukiya,et al.  Development of a Double-Crossover Markerless Gene Deletion System in Bifidobacterium longum: Functional Analysis of the α-Galactosidase Gene for Raffinose Assimilation , 2012, Applied and Environmental Microbiology.

[24]  V. Théodorou,et al.  A marketed fermented dairy product containing Bifidobacterium lactis CNCM I‐2494 suppresses gut hypersensitivity and colonic barrier disruption induced by acute stress in rats , 2012, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[25]  Aldert L. Zomer,et al.  Bifidobacterial surface-exopolysaccharide facilitates commensal-host interaction through immune modulation and pathogen protection , 2012, Proceedings of the National Academy of Sciences.

[26]  C. Grimaldi,et al.  Genome Sequence of the Probiotic Strain Bifidobacterium animalis subsp. lactis CNCM I-2494 , 2011, Journal of bacteriology.

[27]  Aldert L. Zomer,et al.  Functional genome analysis of Bifidobacterium breve UCC2003 reveals type IVb tight adherence (Tad) pili as an essential and conserved host-colonization factor , 2011, Proceedings of the National Academy of Sciences.

[28]  M. O'Connell Motherway,et al.  Metabolism of a plant derived galactose‐containing polysaccharide by Bifidobacterium breve UCC2003 , 2011, Microbial biotechnology.

[29]  M. Hattori,et al.  Bifidobacteria can protect from enteropathogenic infection through production of acetate , 2011, Nature.

[30]  Aldert L. Zomer,et al.  Cellodextrin Utilization by Bifidobacterium breve UCC2003 , 2011, Applied and Environmental Microbiology.

[31]  Wendy S. Garrett,et al.  Bifidobacterium animalis subsp. lactis fermented milk product reduces inflammation by altering a niche for colitogenic microbes , 2010, Proceedings of the National Academy of Sciences.

[32]  G. Ji,et al.  Improvement of transformation efficiency through in vitro methylation and SacII site mutation of plasmid vector in Bifidobacterium longum MG1. , 2010, Journal of microbiology and biotechnology.

[33]  Aldert L. Zomer,et al.  Ribose utilization by the human commensal Bifidobacterium breve UCC2003 , 2010, Microbial biotechnology.

[34]  O. Chassany,et al.  Fermented milk containing Bifidobacterium lactis DN-173 010 improves gastrointestinal well-being and digestive symptoms in women reporting minor digestive symptoms: a randomised, double-blind, parallel, controlled study , 2009, British Journal of Nutrition.

[35]  M. O'Connell Motherway,et al.  Overcoming the restriction barrier to plasmid transformation and targeted mutagenesis in Bifidobacterium breve UCC2003 , 2009, Microbial biotechnology.

[36]  M. Sektas,et al.  M1.MboII and M2.MboII type IIS methyltransferases: different specificities, the same target. , 2009, Microbiology.

[37]  P. Whorwell,et al.  Clinical trial: the effects of a fermented milk product containing Bifidobacterium lactis DN‐173 010 on abdominal distension and gastrointestinal transit in irritable bowel syndrome with constipation , 2009, Alimentary pharmacology & therapeutics.

[38]  Kaori Tanaka,et al.  Improvement of bacterial transformation efficiency using plasmid artificial modification , 2008, Nucleic acids research.

[39]  M. O'Connell Motherway,et al.  Characterization of ApuB, an Extracellular Type II Amylopullulanase from Bifidobacterium breve UCC2003 , 2008, Applied and Environmental Microbiology.

[40]  D. Sinderen,et al.  Functional analysis of the pBC1 replicon from Bifidobacterium catenulatum L48 , 2007, Applied Microbiology and Biotechnology.

[41]  R. Roberts,et al.  A genetic dissection of the LlaJI restriction cassette reveals insights on a novel bacteriophage resistance system , 2006, BMC Microbiology.

[42]  D. van Sinderen,et al.  A dichotomous epigenetic mechanism governs expression of the LlaJI restriction/modification system , 2005, Molecular microbiology.

[43]  D. van Sinderen,et al.  Lactococcal Plasmid pNP40 Encodes a Novel, Temperature-Sensitive Restriction-Modification System , 2004, Applied and Environmental Microbiology.

[44]  D. van Sinderen,et al.  Improvement and Optimization of Two Engineered Phage Resistance Mechanisms in Lactococcus lactis , 2001, Applied and Environmental Microbiology.

[45]  Kim Rutherford,et al.  Artemis: sequence visualization and annotation , 2000, Bioinform..

[46]  T. Kaczorowski,et al.  The FokI methyltransferase from Flavobacterium okeanokoites , 1999, Molecular biotechnology.

[47]  M. Rossi,et al.  Improved cloning vectors for Bifidobacterium spp. , 1998, Letters in applied microbiology.

[48]  Thomas L. Madden,et al.  Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. , 1997, Nucleic acids research.

[49]  W. D. de Vos,et al.  Controlled gene expression systems for Lactococcus lactis with the food-grade inducer nisin , 1996, Applied and environmental microbiology.

[50]  B. Stillman,et al.  Cold Spring Harbor Laboratory , 1995, Molecular medicine.

[51]  G. Venema,et al.  A system to generate chromosomal mutations in Lactococcus lactis which allows fast analysis of targeted genes , 1995, Journal of bacteriology.

[52]  A Janulaitis,et al.  Sequence motifs characteristic for DNA [cytosine-N4] and DNA [adenine-N6] methyltransferases. Classification of all DNA methyltransferases. , 1995, Gene.

[53]  T. Klaenhammer,et al.  In vivo restriction by LlaI is encoded by three genes, arranged in an operon with llaIM, on the conjugative Lactococcus plasmid pTR2030 , 1995, Journal of bacteriology.

[54]  J. Wells,et al.  Improved cloning vectors and transformation procedure for Lactococcus lactis. , 1993, The Journal of applied bacteriology.

[55]  K. Yamamoto,et al.  The HgaI restriction-modification system contains two cytosine methylase genes responsible for modification of different DNA strands. , 1991, The Journal of biological chemistry.

[56]  C. Hill,et al.  In vivo genetic exchange of a functional domain from a type II A methylase between lactococcal plasmid pTR2030 and a virulent bacteriophage , 1991, Journal of bacteriology.

[57]  R. F. Wang,et al.  Construction of versatile low-copy-number vectors for cloning, sequencing and gene expression in Escherichia coli. , 1991, Gene.

[58]  E. Myers,et al.  Basic local alignment search tool. , 1990, Journal of molecular biology.

[59]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[60]  S. G. Hughes,et al.  The nucleotide sequences recognized by endonucleases AvaI and AvaII from Anabaena variabilis. , 1980, Biochemical Journal.

[61]  S. G. Hughes,et al.  Isolation and characterization of two sequence-specific endonucleases from Anabaena variabilis. , 1976, The Biochemical journal.

[62]  B. Bachmann,et al.  Pedigrees of some mutant strains of Escherichia coli K-12. , 1972, Bacteriological reviews.

[63]  M. Rogosa,et al.  A MEDIUM FOR THE CULTIVATION OF LACTOBACILLI , 1960 .